EDITORIAL SECTION

  • STRATEGY

    Smarter Pharma

    Quality management systems QMS are the backbone of pharmaceutical manufacturing ensuring safe products

  • EXPERT Talk

    Where Technology Thinks Small: AI and Nanomedicine in Harmony

    Over the next decade the fusion of nanomedicine and AI will redefine the treatment of neurodegenerative diseases from merely managing symptoms to offering precisionmodifying therapy Smart nanocarriers will be engineered to traverse the bloodbrain barrier target specific brain cells and deliver controlled payloads

KNOWLEDGE BANK

TOP ARTICLES

  • 2

    Exploring the Benefits of Bioassay in Pharmacology

    Harry Callum

    Bioassays, integral to pharmacology, assess drug effects on living organisms. In vitro assays use isolated cells, aiding early drug screening, mechanism understanding, and target validation. In vivo a...

press releases Read more...

Upperton Submits MHRA Licence Application for Annex 1 Sterile Manufacturing Facility Following APS Validation

Upperton has submitted its application to the UK Medicines and Healthcare products Regulatory Agency MHRA for the approval of its new sq ft sterile manufacturing facility The submission follows the successful execution

Frontage Laboratories Completes Acquisition of Teddy Lab, Strengthening Global Central Laboratory Capabilities

Frontage Laboratories Inc Frontage a leading global CROCDMO today announced the completion of the acquisition of Teddy Clinical Research Laboratory Shanghai Ltd Teddy Lab a leading clinical research

FUJIFILM Biotechnologies Unveils ShunzymeX™ precision purification technology

FUJIFILM Biotechnologies a world leading contract development and manufacturing organization CDMO for biologics vaccines and advanced therapies today unveils ShunzymeX precision purification technology

T-knife Therapeutics Announces Authorization of Clinical Trial Application for TK-6302, A Multi-Armored, CRISPR based T cell Therapy for Solid Tumors

Tknife Therapeutics Inc a biopharmaceutical company developing nextgeneration T cell therapies to fight cancer today announced the authorization of its Clinical Trial Application CTA to begin the Phase ATLAS trial of TK in Europe

09 - 11

Mar 2026

8th International Conference

8105, Suite 112, Rasor Blvd, Plano TX 75024, USA

10 - 12

Mar 2026

Bioprocessing Summit Europe 2026

InterContinental Barcelona, Spain

10 - 10

Mar 2026

Age of AI Europe 2026

Institute of Engineering and Technology (IET) London,UK

10 - 12

Mar 2026

10 - 12

Mar 2026

16 - 17

Mar 2026

Pharma USA 2026

Philadelphia, PA, USA

16 - 18

Mar 2026

Pharmaceutics and Novel Drug

Kuala Lumpur, Malaysia

16 - 18

Mar 2026

Advanced Clinical Research

Kuala Lumpur, Malaysia

LATEST NEWS Read more...

EU Health Package Boosts Biotech and Clinical Trials

The European Commissions Health Package introduces the EU Biotech Act and accelerates clinical trial procedures to enhance Europes life sciences competitiveness

EU Health Package Boosts Biotech and Clinical Trials

The European Commissions Health Package introduces the EU Biotech Act and accelerates clinical trial procedures to enhance Europes life sciences competitiveness

EU Launches Health Package with Biotech Act and Clinical Trial Accelerations

The European Commission has introduced a comprehensive Health Package including the first phase of the EU Biotech Act and amendments to clinical trials regulation to boost competitiveness and resilience in life sciences

Vericel Receives FDA Approval for Advanced Therapy Manufacturing Plant

Vericel Corporation has received approval from the US Food and Drug Administration to begin commercial manufacturing of MACI at its advanced cell therapy manufacturing plant in Burlington Massachusetts

Antengene and UCB Sign Global Licence Agreement for ATG-201 in Autoimmune Diseases

Antengene Corporation Limited and UCB have entered into a global licence agreement for ATG a CDCD bispecific Tcell engager TCE for autoimmune diseases

EU Advances Critical Medicines Act for Supply Chain Resilience

The EU Parliament has advanced the Critical Medicines Act to enhance pharmaceutical supply chain security and resilience across Europe starting in